Clinical Trials
67 trialsAn Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
NRG Oncology
Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients
University of Cincinnati
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Dana-Farber Cancer Institute
Metformin to Mitigate Sequelae of Radioactive Iodine Treatment for Thyroid Cancers
Thomas Jefferson University
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Columbia University
An Endometrial Cancer Chemoprevention Study of Metformin
M.D. Anderson Cancer Center
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
Thomas Jefferson University
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
UNC Lineberger Comprehensive Cancer Center
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
Emory University
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Metformin Hydrochloride in Treating Women With Stage I or Stage II Breast Cancer That Can Be Removed By Surgery
Vanderbilt-Ingram Cancer Center
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Xinqiao Hospital of Chongqing
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
Dartmouth-Hitchcock Medical Center
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
Canadian Cancer Trials Group
Phase I/II Study OF Metformin in Combination With Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
Baylor College of Medicine
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
University of Arizona
PRIMA
Rutgers, The State University of New Jersey
Pre-Surgical Study: Effect of Metformin on Breast Cancer Proliferation
Columbia University
Metformin Prostate Cancer Adjuvant Trial
NYU Langone Health
DLBCL
Rush University Medical Center
BIMET-1
Fox Chase Cancer Center
PULSE
Pennington Biomedical Research Center
DPPOS
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
GOG Foundation
Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer
Case Comprehensive Cancer Center
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Ozmosis Research Inc.
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Woman's
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Effect of Metformin on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
University of Virginia
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Northwestern University
Exemestane-RAD001-Metformin
M.D. Anderson Cancer Center
Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
University of Cincinnati
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
University of California, San Diego
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer
Mayo Clinic
Treatment With Metformin and Combination of Metformin and Pioglitazone in Polycystic Ovarian Syndrome
Khyber Medical University Peshawar
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer
Avera McKennan Hospital & University Health Center
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
National Cancer Institute (NCI)
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Northwestern University
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exercise and Metformin in Colorectal and Breast Cancer Survivors
Dana-Farber Cancer Institute
Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients
University of Michigan Rogel Cancer Center
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
The University of Texas Health Science Center at San Antonio
METRO
Beth Israel Medical Center